![](/img/cover-not-exists.png)
A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma: a prospective randomised phase III study
M. van Agthoven, C.M. Segeren, I. Buijt, C.A. Uyl-de Groot, B. van der Holt, H.M. Lokhorst, P. SonneveldVolume:
40
Year:
2004
Language:
english
Pages:
1170
DOI:
10.1016/j.ejca.2004.01.019
File:
PDF, 334 KB
english, 2004